These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23086966)

  • 1. Thromboprophylaxis of elderly patients with AF in the UK: an analysis using the General Practice Research Database (GPRD) 2000-2009.
    Scowcroft AC; Lee S; Mant J
    Heart; 2013 Jan; 99(2):127-32. PubMed ID: 23086966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S; Bennett D; Smith DJ
    Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
    Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB
    J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The costs of warfarin underuse and nonadherence in patients with atrial fibrillation: a commercial insurer perspective.
    Casciano JP; Dotiwala ZJ; Martin BC; Kwong WJ
    J Manag Care Pharm; 2013 May; 19(4):302-16. PubMed ID: 23627576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latent Classes of Adherence to Oral Anticoagulation Therapy Among Patients With a New Diagnosis of Atrial Fibrillation.
    Chen N; Brooks MM; Hernandez I
    JAMA Netw Open; 2020 Feb; 3(2):e1921357. PubMed ID: 32074287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and predictors of warfarin use in patients with atrial fibrillation at low or intermediate risk and relation to thromboembolic events.
    Chae SH; Froehlich J; Morady F; Oral H
    Clin Cardiol; 2011 Oct; 34(10):640-4. PubMed ID: 21994084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
    Cullen MW; Kim S; Piccini JP; Ansell JE; Fonarow GC; Hylek EM; Singer DE; Mahaffey KW; Kowey PR; Thomas L; Go AS; Lopes RD; Chang P; Peterson ED; Gersh BJ;
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):461-9. PubMed ID: 23759473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice.
    Van Staa TP; Setakis E; Di Tanna GL; Lane DA; Lip GY
    J Thromb Haemost; 2011 Jan; 9(1):39-48. PubMed ID: 21029359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of oral anticoagulants in older people with atrial fibrillation in UK general practice: protocol for a cohort study using the Clinical Practice Research Datalink (CPRD) database.
    Mitchell A; Welsh TJ; Watson MC; Snowball J; McGrogan A
    BMJ Open; 2019 Dec; 9(12):e032646. PubMed ID: 31843842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trial.
    Oldgren J; Alings M; Darius H; Diener HC; Eikelboom J; Ezekowitz MD; Kamensky G; Reilly PA; Yang S; Yusuf S; Wallentin L; Connolly SJ;
    Ann Intern Med; 2011 Nov; 155(10):660-7, W204. PubMed ID: 22084332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).
    Steinberg BA; Shrader P; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Hylek E; Kowey PR; Mahaffey KW; O'Brien EC; Singer DE; Peterson ED; Piccini JP;
    Am Heart J; 2017 Jul; 189():40-47. PubMed ID: 28625380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time Trends of Aspirin and Warfarin Use on Stroke and Bleeding Events in Chinese Patients With New-Onset Atrial Fibrillation.
    Guo Y; Wang H; Tian Y; Wang Y; Lip GYH
    Chest; 2015 Jul; 148(1):62-72. PubMed ID: 25501045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort.
    Shantsila E; Wolff A; Lip GY; Lane DA
    Br J Gen Pract; 2015 Jan; 65(630):e16-23. PubMed ID: 25548312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome in Japanese elderly patients with non-valvular atrial fibrillation taking warfarin: a single-center observational study.
    Naganuma M; Shiga T; Sato K; Murasaki K; Hashiguchi M; Mochizuki M; Hagiwara N
    Thromb Res; 2012 Jul; 130(1):21-6. PubMed ID: 22137743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Bleeding Risk and Frailty Status on Anticoagulation Patterns in Octogenarians With Atrial Fibrillation: The FRAIL-AF Study.
    Lefebvre MC; St-Onge M; Glazer-Cavanagh M; Bell L; Kha Nguyen JN; Viet-Quoc Nguyen P; Tannenbaum C
    Can J Cardiol; 2016 Feb; 32(2):169-76. PubMed ID: 26277091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can we predict stroke in atrial fibrillation?
    Lip GY
    Clin Cardiol; 2012 Jan; 35 Suppl 1(Suppl 1):21-7. PubMed ID: 22246948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of chronic atrial fibrillation in general practice and its treatment pattern.
    Ruigómez A; Johansson S; Wallander MA; Rodríguez LA
    J Clin Epidemiol; 2002 Apr; 55(4):358-63. PubMed ID: 11927203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation therapy for patients with non-valvular atrial fibrillation: comparison of decision analytic model recommendations and real-world warfarin prescription use.
    Casciano JP; Singer DE; Kwong WJ; Fox ES; Martin BC
    Am J Cardiovasc Drugs; 2012 Oct; 12(5):313-23. PubMed ID: 22920047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.